New Cepheid GeneXpert Omni at #AACC2015

With my recent transition to the clinical market segment with SeraCare, their majorĀ  conference for the year is the American Association for Clinical Chemistry. With some 20,000 attendees, and several hundred vendors filling the Atlanta Convention Center, there were a number of interesting real-time instruments shown. I’ll start with the […]

Cepheid's GeneXpert Omni, unveiled at the 2015 AACC Conference

Seracare precision medicine ngs control reference material seraseq mutation mix

SeraCare Precision Oncology

This post is about Seracare’s new direction for Precision Medicine (in particular Precision Oncology), and the launch of a new product the Seraseq Solid Tumor Mutation Mix-I (AF20). But I’ll start first with a story from my days at Illumina. It was ten years ago this week that I last […]

One door opens, and another door closes

One way the world of work has changed with the advent of social media has been the immediacy and intimacy of information. Immediate, as the ability to push ‘tweet’ or ‘publish’ sends your message or blog post out into the vast reaches of electronic communication; and intimate, as social media […]


Complete human diplotypes & Google X Life Sciences podcast

Theral Timpson produces a weekly podcast at, and in his latest edition he interviews me about Google X Life Sciences (I wrote about them before here), long-read sequencing (in particular Pacific Biosciences) which then I’m able to discuss the value of complete human diploid sequencing, and my involvement with […]


Craig Venter presenting at the Pacific Biosciences workshop; Deanna Church (Personalis) in the foreground

A few observations from Advances in Genome Biology and Technology

In the closing session of the Advances in Genome Biology and Technology meeting recently concluded in Marco Island, Florida, the main organizers Dr. Eric Green (National Human Genome Research Institute Director, Bethesda MD) and Dr. Elaine Mardis (Co-director with Rick Wilson of the Genome Institute of Washington University, St. Louis […]

Marketing Precision Medicine Pt2

After writing up ‘Marketing Precision Medicine’ it turned out that I spent so much time in giving the background and context, that I only was able to mention briefly the marketing challenge that the Precision Medicine Initiative brings. So here is Part 2, getting deeper into the Marketing challenge of […]

Borrowed from this infographic:

Marketing Precision Medicine

Last week I listened in with interest on the Precision Medicine Workshop held at the NIH, and wrote up some thoughts about the need for them to market it effectively. You can access this post on LinkedIn – something of an experiment in posting in various places. We are living […]